Cargando…
Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus
BACKGROUND: The mechanisms leading to the high on-treatment platelet reactivity in diabetes patients are not fully elucidated. The genetic factors may be associated with the diminished antiplatelet efficacy of dual antiplatelet therapy. We investigated the possible association between insulin recept...
Autores principales: | Zhang, Dingyu, Zhang, Xiaolin, Liu, Dan, Liu, Tengfei, Cai, Wenzhi, Yan, Chenghui, Han, Yaling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804508/ https://www.ncbi.nlm.nih.gov/pubmed/27005817 http://dx.doi.org/10.1186/s12933-016-0362-0 |
Ejemplares similares
-
Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome
por: García-Lagunar, María Henar, et al.
Publicado: (2017) -
Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel
por: Li, Qing, et al.
Publicado: (2021) -
The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions
por: Tekkeşin, Ahmet İlker, et al.
Publicado: (2016) -
Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment
por: Yu, Shushu, et al.
Publicado: (2023) -
The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study
por: Schuette, Claudia, et al.
Publicado: (2015)